| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.18B | 85.93B | 78.76B | 73.31B | 56.05B | 40.59B |
| Gross Profit | 31.86B | 33.34B | 30.42B | 29.01B | 25.66B | 19.49B |
| EBITDA | 7.86B | 8.50B | 7.70B | 6.32B | 7.26B | 4.24B |
| Net Income | 3.66B | 4.42B | 4.10B | 3.04B | 3.65B | 1.13B |
Balance Sheet | ||||||
| Total Assets | 81.68B | 82.23B | 70.53B | 62.80B | 59.49B | 58.52B |
| Cash, Cash Equivalents and Short-Term Investments | 2.94B | 4.43B | 1.42B | 3.37B | 8.71B | 4.18B |
| Total Debt | 7.77B | 6.20B | 1.02B | 156.20M | 97.40M | 2.62B |
| Total Liabilities | 38.19B | 38.53B | 28.70B | 23.11B | 20.10B | 22.66B |
| Stockholders Equity | 43.43B | 43.64B | 41.78B | 39.65B | 39.35B | 35.82B |
Cash Flow | ||||||
| Free Cash Flow | 231.70M | -232.50M | -1.22B | -2.76B | 7.26B | 4.20B |
| Operating Cash Flow | 4.53B | 2.35B | 695.00M | -1.20B | 9.00B | 6.20B |
| Investing Cash Flow | -4.21B | -2.39B | -1.48B | -1.21B | -1.60B | -1.52B |
| Financing Cash Flow | -2.05B | 2.17B | -1.22B | -2.92B | -2.87B | -883.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹24.11B | 16.42 | ― | 0.72% | ― | ― | |
66 Neutral | ₹104.90B | -24.49 | ― | 0.21% | 3.35% | 56.08% | |
65 Neutral | ₹392.88B | 132.49 | ― | 0.62% | 8.08% | -22.42% | |
64 Neutral | ₹13.79B | 16.60 | ― | 0.21% | 16.02% | 48.63% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹13.68B | 121.41 | ― | ― | -0.87% | 10.87% | |
57 Neutral | ₹13.22B | 50.36 | ― | 1.67% | -2.15% | -42.78% |